The derivatives of quinazolinone can exert anti-tumour activity by inhibiting EGFR-TK, cyclin dependent kinase 4 (CDK4)10, tubulin polymerization11, HER212, VEGFR13 and c-Met.14 This evidence concerns the gene CDK4 and neoplasm.